相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes
Ryo Kodera et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats
Nattayaporn Apaijai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
Junichi Matsubara et al.
CIRCULATION JOURNAL (2013)
Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
Belen Picatoste et al.
PLOS ONE (2013)
Novel therapies for the management of type 2 diabetes mellitus: Part 2. Addressing the incretin defect in the clinical setting in 2013
George Grunberger
JOURNAL OF DIABETES (2013)
DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials
A. J. Scheen
DIABETES & METABOLISM (2012)
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model
A. Goncalves et al.
DIABETES OBESITY & METABOLISM (2012)
Inflammation in Diabetic Nephropathy
Andy K. H. Lim et al.
MEDIATORS OF INFLAMMATION (2012)
Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs) - induced apoptosis
Yi Zhan et al.
MEDICAL SCIENCE MONITOR (2012)
GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases
Hari Hendarto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
Wei Jing Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
A. D. Dobrian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries
Veerle Matheeussen et al.
BIOLOGICAL CHEMISTRY (2011)
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
R. Kodera et al.
DIABETOLOGIA (2011)
Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)
Cristina Mega et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes
Jitendra Vaghasiya et al.
REGULATORY PEPTIDES (2011)
DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease
Philip A. Read et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2010)
Exendin-4 Prevents c-Jun N-Terminal Protein Kinase Activation by Tumor Necrosis Factor-alpha (TNF alpha) and Inhibits TNF alpha-Induced Apoptosis in Insulin-Secreting Cells
Annalisa Natalicchio et al.
ENDOCRINOLOGY (2010)
GLP-1 Mediates Antiapoptotic Effect by Phosphorylating Bad through a β-Arrestin 1-mediated ERK1/2 Activation in Pancreatic β-Cells
Julie Quoyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
New paradigms in cell death in human diabetic nephropathy
Maria-Dolores Sanchez-Nino et al.
KIDNEY INTERNATIONAL (2010)
Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
Liliana Ferreira et al.
MEDIATORS OF INFLAMMATION (2010)
Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway
Jian-hui Liu et al.
ACTA PHARMACOLOGICA SINICA (2009)
The role of reactive oxygen species in apoptosis of the diabetic kidney
F. A. D. T. G. Wagener et al.
APOPTOSIS (2009)
Pathogenic perspectives for the role of inflammation in diabetic nephropathy
Antonio Rivero et al.
CLINICAL SCIENCE (2009)
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
G. M. Magee et al.
DIABETOLOGIA (2009)
Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis
M. Marzioni et al.
GUT (2009)
Anti-apoptotic Action of Exendin-4 in INS-1 Beta Cells: Comparative Protein Pattern Analysis of Isolated Mitochondria
D. Tews et al.
HORMONE AND METABOLIC RESEARCH (2009)
Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats
Yasushi Kirino et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Oxidative stress as a major culprit in kidney disease in diabetes
Josephine M. Forbes et al.
DIABETES (2008)
Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
Kenji Nonaka et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Diabetic nephropathy: Mechanisms of renal disease progression
Yashpal S. Kanwar et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
J. A. Jefferson et al.
KIDNEY INTERNATIONAL (2008)
Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-β peptide (1-42)
Zhenxia Qin et al.
NEUROSCIENCE LETTERS (2008)
The pathogenesis of diabetic nephropathy
Suma Dronavalli et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
Sakiko Ohga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice
Volha Ninichuk et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
Pablo Aschner et al.
DIABETES CARE (2006)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
I. Raz et al.
DIABETOLOGIA (2006)
DPP-4 inhibitors and their potential role in the management of type 2 diabetes
A. Barnett
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy
Juan F. Navarro et al.
THESCIENTIFICWORLDJOURNAL (2006)
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes
James Mu et al.
DIABETES (2006)
Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes
YG Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice
FY Chow et al.
KIDNEY INTERNATIONAL (2006)
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy
K Susztak et al.
DIABETES (2006)
Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions
K Yozai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats
A Tone et al.
DIABETOLOGIA (2005)
Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function
CL Nelson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression
SJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes
M Dalla Vestra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
D Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells
L Pala et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
M Saraheimo et al.
DIABETOLOGIA (2003)
Activation of tubular epithelial cells in diabetic nephropathy
M Morcos et al.
DIABETES (2002)
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
Q Wang et al.
DIABETOLOGIA (2002)
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes
B Ahrén et al.
DIABETES CARE (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Transcription factor-κB (NF-κB) and renal disease
C Guijarro et al.
KIDNEY INTERNATIONAL (2001)
分享论文
